Summary & Overview
HCPCS G8859: Prolonged Systemic Corticosteroid Therapy, ≥10 mg/day ≥60 days
HCPCS Level II code G8859 identifies patients receiving systemic corticosteroids at doses of at least 10 mg/day for 60 or more consecutive days. Nationally, this code matters because prolonged corticosteroid exposure is associated with elevated risk of adverse events and often triggers enhanced monitoring, care coordination, and quality-measure reporting. Use of G8859 supports documentation for chronic steroid management across outpatient and specialty settings.
Key payers included in this coverage overview are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, typical clinical contexts in which it is reported, and the common service settings where it is applied. The publication also outlines expected benchmarks and areas of policy relevance such as documentation requirements, implications for utilization management, and how the code is used in quality measurement frameworks.
This summary is written for a national audience and provides operational clarity for billing staff, clinical documentation specialists, and policy analysts seeking to understand how prolonged corticosteroid therapy is recorded and tracked using HCPCS Level II code G8859. Data not available in the input is noted where applicable in the full content sections.
Billing Code Overview
HCPCS Level II code G8859 describes a patient who is receiving corticosteroids greater than or equal to 10mg/day for 60 or greater consecutive days. This code is used to document prolonged systemic corticosteroid therapy for clinical tracking and billing purposes.
-
Service type: Prolonged outpatient medication therapy monitoring and documentation
-
Typical site of service: Ambulatory care settings, outpatient clinics, and specialty practices where long-term corticosteroid management is provided
Clinical & Coding Specifications
Clinical Context
A 62-year-old female with severe rheumatoid arthritis has been treated with oral prednisone at a maintenance dose of 10 mg daily for 12 weeks due to recurrent flare activity and intolerance to steroid-sparing agents. During a routine outpatient follow-up in a rheumatology clinic, the clinician documents continuous systemic corticosteroid therapy of at least 10 mg/day for 60+ consecutive days and reviews infection risk, bone health, blood glucose control, and vaccination status. The clinical workflow includes verification of the steroid dosing history in the electronic medical record, problem-list and medication reconciliation, ICD-10 diagnosis confirmation, and capture of the HCPCS Level II code G8859 on the claim to indicate chronic corticosteroid exposure. Typical encounters capturing this code occur in outpatient specialty clinics (rheumatology, pulmonology, endocrinology), primary care offices managing long-term systemic corticosteroids, and transitional care visits where medication reconciliation and risk mitigation are performed. Ancillary tasks during the visit often include ordering bone density testing, laboratory monitoring (glucose, electrolytes), medication counseling, and coordination with pharmacies for steroid taper plans or steroid-sparing therapy referrals.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |